Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$2.49B |
| 2 |
NVIDIA
NVDA
|
+$2.19B |
| 3 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$1.94B |
| 4 |
TSMC
TSM
|
+$728M |
| 5 |
UnitedHealth
UNH
|
+$705M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$775M |
| 2 |
AbbVie
ABBV
|
+$540M |
| 3 |
Delta Air Lines
DAL
|
+$434M |
| 4 |
Eli Lilly
LLY
|
+$433M |
| 5 |
DexCom
DXCM
|
+$433M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.89% |
| 2 | Healthcare | 2.92% |
| 3 | Financials | 2.71% |
| 4 | Consumer Discretionary | 2.52% |
| 5 | Industrials | 2.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
8576
PUT
Citi Trends
CTRN
$555M
| $594K | ﹤0.01% |
+14,300
| New | +$565K |
|
8577
Coursera
COUR
$1.52B
| $594K | ﹤0.01% |
80,684
-136,527
| -63% | -$1.19M |
|
8578
ALPS Dynamic US Dividend Advantage ETF
RFDA
$88.1M
| $594K | ﹤0.01% |
+9,313
| New | +$589K |
|
8579
CALL
Avista
AVA
$3.34B
| $594K | ﹤0.01% |
15,400
+2,900
| +23% | +$113K |
|
8580
ClearPoint Neuro
CLPT
$448M
| $593K | ﹤0.01% |
43,364
-43,128
| -50% | -$799K |
|
8581
CALL
National Beverage
FIZZ
$2.96B
| $593K | ﹤0.01% |
18,600
-9,500
| -34% | -$327K |
|
8582
CP High Yield Trend ETF
HYTR
$290M
| $592K | ﹤0.01% |
27,267
+9,244
| +51% | +$201K |
|
8583
Core Laboratories
CLB
$488M
| $592K | ﹤0.01% |
36,933
-144,514
| -80% | -$2.15M |
|
|
BRR
8584
CALL
ProCap Financial Inc
BRR
$154M
| $591K | ﹤0.01% |
167,500
+97,200
| +138% | +$775K |
|
8585
FT Vest US Equity Deep Buffer ETF March
DMAR
$454M
| $591K | ﹤0.01% |
14,188
-6,029
| -30% | -$248K |
|
8586
CALL
ProFrac Holding
ACDC
$731M
| $590K | ﹤0.01% |
151,700
+59,900
| +65% | +$245K |
|
8587
BondBloxx Bloomberg Three Year Target Duration US Treasury ETF
XTRE
$180M
| $589K | ﹤0.01% |
+11,839
| New | +$590K |
|
8588
First Trust Expanded Technology ETF
XPND
$37.8M
| $589K | ﹤0.01% |
+16,308
| New | +$596K |
|
8589
PUT
Ameresco
AMRC
$1.12B
| $589K | ﹤0.01% |
20,100
-55,600
| -73% | -$1.95M |
|
8590
First Community Corp
FCCO
$321M
| $588K | ﹤0.01% |
+19,848
| New | +$562K |
|
|
UROY
8591
PUT
Uranium Royalty Corp
UROY
$1.3B
| $588K | ﹤0.01% |
166,200
-120,900
| -42% | -$473K |
|
8592
Genmab
GMAB
$17.7B
| $588K | ﹤0.01% |
19,102
-32,371
| -63% | -$1.01M |
|
8593
CALL
YieldMax Ultra Option Income Strategy ETF
ULTY
$762M
| $588K | ﹤0.01% |
15,750
-15,910
| -50% | -$716K |
|
8594
CALL
Teekay Tankers
TNK
$2.75B
| $588K | ﹤0.01% |
11,000
-27,300
| -71% | -$1.53M |
|
|
XRPC
8595
CALL
Canary XRP ETF
XRPC
$221M
| $587K | ﹤0.01% |
+30,200
| New | +$653K |
|
8596
CALL
Dime Commercial Bancshares
DCOM
$1.8B
| $587K | ﹤0.01% |
+19,500
| New | +$563K |
|
8597
Woori Financial
WF
$16.7B
| $587K | ﹤0.01% |
+9,980
| New | +$556K |
|
8598
PUT
Atmos Energy
ATO
$28.8B
| $587K | ﹤0.01% |
3,500
-5,700
| -62% | -$986K |
|
|
DYNC
8599
CALL
Dynamix Corp
DYNC
$240M
| $587K | ﹤0.01% |
57,000
+13,900
| +32% | +$144K |
|
|
FSGS
8600
First Trust SMID Growth Strength ETF
FSGS
$30.9M
| $586K | ﹤0.01% |
19,270
-16,049
| -45% | -$493K |
|
Similar funds
Citadel Advisors's Q4 2025 Portfolio in Review
As of Q4 2025, Citadel Advisors held 14,701 positions worth $666B, up 1.3% from $657B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Citadel Advisors's Q4 2025 filing shows 2,078 new, 5,000 increased, 5,363 reduced and 2,191 closed positions. Its largest new stake was Medline Inc: 6,006,339 shares worth $252M. The largest sale was Meta Platforms (Facebook), an estimated $775M.
By sector, the portfolio is most concentrated in Technology at 4.9% of assets, up from 3.8% a quarter earlier, followed by Healthcare and Financials.
- Citadel Advisors's largest Q4 2025 buy was Medline Inc: 6,006,339 shares worth $252M.
- Citadel Advisors added most to Amazon in Q4 2025, an estimated $2.49B increase.
- Citadel Advisors's biggest Q4 2025 reduction was Meta Platforms (Facebook), cutting an estimated $775M.
- Citadel Advisors fully exited WEX in Q4 2025, selling an estimated $131M.
- Citadel Advisors's ten largest holdings make up 23% of its $666B portfolio in Q4 2025.
- Citadel Advisors opened 2,078 new positions and closed 2,191 in Q4 2025.
- Citadel Advisors's portfolio value rose 1.3% quarter-over-quarter to $666B.
Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.